Loading
Latest filing published 28 Aug 2017 for Cardiome Pharma Corp..
No signal scores available.
Mark Corrigan discloses dealings in Cardiome Pharma Corp. to SEDI. In total, 2 filings cover trades dated from 22 June 2015 to 25 August 2017.
On the market, this insider has only ever bought: 1 purchase, €15k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2017 alone, the filings show 1 purchase and no sales.
Most recently, on 28 August 2017, the filings show a transaction in Cardiome Pharma Corp. The most recent open-market purchase was published on 28 August 2017, 3,345 days ago. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations